ArticleFrontiers in oncology2026
Metachronous cholangiocarcinoma following pancreaticoduodenectomy and the potential role of a migrated pancreaticojejunal stent: a case report and review of the literature.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metachronous cholangiocarcinoma following curative surgery for periampullary neoplasia is a rare but serious long-term complication that poses significant diagnostic and management challenges. We report the case of a 62-year-old male who developed hilar cholangiocarcinoma 9 years after undergoing a pancreaticoduodenectomy (Whipple procedure) for an ampullary adenoma. The patient was initially diagnosed with a duodenal papillary villous tubular adenoma showing moderate dysplasia in 2015 and underwent curative resection, with no evidence of recurrence during subsequent follow-up. In 2024, he presented with obstructive jaundice and imaging findings revealing a hepatic hilar mass with intrahepatic biliary dilation. A biopsy confirmed a poorly differentiated cholangiocarcinoma (Klatskin tumor). Crucially, intraoperative exploration identified migration of the internal pancreaticojejunostomy stent to a site adjacent to the biliary-enteric anastomosis. Immunohistochemical analysis demonstrated wild-type P53 expression and proficient mismatch repair function, supporting a sporadic rather than hereditary origin. This case underscores the importance of considering second primary malignancies in patients with late-onset biliary obstruction after pancreaticoduodenectomy. We propose that the migrated and retained pancreatic stent may have acted as a chronic local irritant, potentially exacerbating inflammation and contributing to carcinogenesis within the biliary-enteric anastomotic milieu, thereby highlighting a possible long-term risk associated with indwelling surgical stents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.